Why the study?
Preliminary study showed ginsenoside Rg3 induces apoptosis in hepatocellular carcinoma in vitro, but the cross-link between apoptosis induction and antiangiogenesis effects on orthotopic HCC in vivo was uninvestigated.
Does ginsenoside Rg3 improve survival and inhibit tumor growth in a mouse model of orthotopic hepatocellular carcinoma?
Comparison
Oral ginsenoside Rg3 (10 mg/kg once a day for 30 days) vs control
Design
In vivo animal study
Authors
Loading...
Does not support clinical use of Rg3 in HCC; leaves open translation from orthotopic mouse models.
Does ginsenoside Rg3 improve survival and inhibit tumor growth in a mouse model of orthotopic hepatocellular carcinoma?
Ginsenoside Rg3 prolongs survival and reduces tumor growth in a mouse model of hepatocellular carcinoma by inducing apoptosis and inhibiting angiogenesis.
Hu et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: